Follicle-stimulating hormone receptor: Advances and remaining challenges
Follicle-stimulating hormone (FSH) is produced in the pituitary and is essential for reproduction. It specifically binds to a membrane receptor (FSHR) expressed in somatic cells of the gonads. The FSH/FSHR system presents many peculiarities compared to classical G protein-coupled receptors (GPCRs). FSH is a large naturally heterogeneous heterodimeric glycoprotein. The FSHR is characterized by a very large NH2-terminal extracellular domain, which binds the FSH and participates to the activation/inactivation switch of the receptor. Once activated, the FSHR couples to G{\alpha}s and, in some instances, to other G{\alpha} subunits. G protein-coupled receptor kinases and \beta-arrestins are also recruited to the FSHR and account for its desensitization, the control of its trafficking and its intracellular signalling. Of note, the FSHR internalization and recycling are very fast and involve very early endosomes instead of early endosomes. All the transduction mechanisms triggered upon FSH stimulation lead to the activation of a complex signalling network that controls gene expression by acting at multiple levels. The integration of these mechanisms leads to context-adapted responses from the target gonadal cells, but also indirectly affects the fate of germ cells. Depending of the physiological/developmental stage, FSH elicits proliferation, differentiation or apoptosis in order to maintain the homeostasis of the reproductive system. Pharmacological tools targeting FSHR recently came to the fore and open promising prospects both for basic research and therapeutic applications. This paper provides an updated review of the most salient aspects and peculiarities of FSHR biology and pharmacology.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Computational modeling approaches in gonadotropin signaling
Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) play essential roles in animal reproduction. They exert their function through binding to their cognate receptors, which belong to the large family of G pro…
Drug DiscoveryWorkflow description to dynamically model \beta-arrestin signaling networks
Dynamic models of signaling networks allow the formulation of hypotheses on the topology and kinetic rate laws characterizing a given molecular network, in-depth exploration and confrontation with kinetic biological data…
Screening of BindingDB database ligands against EGFR, HER2, Estrogen, Progesterone and NF-kB receptors based on machine learning and molecular docking
Breast cancer, the second most prevalent cancer among women worldwide, necessitates the exploration of novel therapeutic approaches. To target the four subgroups of breast cancer "hormone receptor-positive and HER2-negat…
Molecular DockingFMO Interaction Energy between 17$β$-Estradiol, 17$α$-Estradiol and Human Estrogen Receptor $α$
The estrogen receptor is a nuclear hormone receptor activated by the natural steroid hormone 17$\beta$-estradiol (E2). Fragment molecular orbital (FMO) calculations were performed which allowed us to obtain the interacti…
Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors
Human luteinizing hormone (LH) and chorionic gonadotropin (hCG) have been considered biologically equivalent because of their structural similarities and their binding to the same receptor; the LH/CGR. However, accumulat…